2004 West Coast Worm Meeting abstract 78

These abstracts should not be cited in bibliographies. Material contained herein should be treated as personal communication and should be cited as such only with the consent of the author.

acr-16 mutants eliminate the non-levamisole acetylcholine response in C. elegans body wall muscles

Denis V.Touroutine1, Rebecca M. Fox2, David M Miller, III2, Janet E. Richmond1

1 Dept.of Biological Sciences, University of Illinois at Chicago, IL, 60607.
2 Dept of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville 37232.

C. elegans  body wall muscles have two pharmacologically distinct  acetylcholine receptors (AChR) ( Richmond and Jorgensen, 1999): a levamisole-sensitive receptor that contains  UNC-38, UNC-63,  UNC-29 and LEV-1 subunits and  a previously unidentified  nicotine-sensitive receptor that is selectively blocked by DHbE.

          To identify components of the non-levamisole-sensitive  receptor, we examined an Affymetrix microarray data set obtained from  FACS-isolated myo-3::GFP muscle cells. ACR-16 mRNA was among several nAChR subunits found to be enriched in muscle. Ballivet et.al. (1996) have shown that heterologously expressed ACR-16 forms a functional homomeric receptor that pharmacologically resembles the native non levamisole-sensitive receptor in C. elegans  body wall muscle.   

          To test whether ACR-16 contributes to the ACh response in body wall muscle, we have characterized a deletion mutant obtained from the knockout consortium, acr-16(ok789). This mutant does not exhibit obvious locomotion defects. However, electrophysiological recordings revealed that the ACh response is reduced by 88% in acr-16(ok789) compared to the wild type.  Similarly, the nicotine response is reduced by 87%, whereas the levamisole response is unaffected.  These electrophysiological defects can be fully rescued by expressing ACR-16 under the control of the myo-3 promoter in muscles.  Evoked responses in acr-16 (ok789) are also dramatically reduced (86%), suggesting that activation of the ACR-16 receptor contributes the majority of peak evoked response.

          We have made double mutants between acr-16 (ok789) and the levamisole receptor subunit mutants unc-29 and unc-63. These double mutants have a more severe uncoordinated phenotype than either unc-63 or unc-29 mutants alone and the muscle ACh response is reduced by 98% relative to wildtype. These results suggest that both, the levamisole-receptor and the ACR-16 dependent receptor contribute to locomotion in C. elegans.